ArticleJournal of maxillofacial and oral surgery2025
Inflammatory Myofibroblastic Tumor of Maxilla; A Rare Entity to Encounter: from Resection to Rehabilitation-A Case Report with Review of Literature.
Article in Journal of maxillofacial and oral surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory myofibroblastic tumors are mesenchymal tumors typically found in the lung, abdominopelvic, and retroperitoneal regions, though they can occur throughout the body, with rare instances affecting the head and neck region. They present a diverse immunohistochemical profile, making diagnosis primarily reliant on such findings. Notably, fewer than fifty cases involving the head and neck, particularly the maxilla, have been reported in the literature, highlighting its rarity in this anatomical site. Herein, we report a case of IMT in the maxilla, managed through surgical excision and defect reconstruction using Patient-Specific Implants. Timely diagnosis is crucial to prevent potential morbidity, as undiagnosed cases may manifest as aggressive lesions. Thus, prompt intervention is imperative for optimal patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.